Strategic research pillars

ICB is unique in Greece in Drug research employing a comprehensive integrated approach encompassing all the stages of Drug discovery (structural biology, design, synthesis, biological evaluation in vitro, ex vivo and in vivo, development of nanocarriers for effective delivery) combined with translational research (collaboration with clinicians, biomarker, big data analysis).

ICB applies a combination of holistic chemical, biological and computational technologies (genomics, epigenomics, proteomics, transcriptomics and metabolomics) to characterize a wide range of samples, to study the mechanism of disease onset and progression and the efficacy/toxicity of drugs and other therapeutic approaches, and for the discovery of biomarkers related to environmental exposure, population heterogeneity, disease pathogenesis and development of drug resistance.

ICB applies biotechnological approaches, nanotechnology and green chemistry to produce compounds and nanocarriers with applications in food, pharmaceuticals, cosmetics and chemicals.